Results 151 to 160 of about 458,337 (361)
Predicting optimal impact interventions in the post‐HPV vaccination world
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Matti Lehtinen +7 more
wiley +1 more source
Cytologic findings of uterine leiomyosarcoma associated with infection: Report of a case.
Toshihiko Toki +4 more
openalex +2 more sources
Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression [PDF]
Işın Soyuer +4 more
openalex +1 more source
What's New? The understanding of the epidemiological and clinical distinctions between Epstein–Barr virus (EBV)‐positive and EBV‐negative classic Hodgkin lymphoma remains incomplete. Here, the authors generated unique sets of population‐based sex‐ and age‐specific incidence rates of classic Hodgkin lymphoma in Denmark stratified by histological subtype
Klaus Rostgaard +18 more
wiley +1 more source
Clinical Evaluation of Cytology and Histology for Gastric Malignancy
Hirofumi Kudoh +6 more
openalex +2 more sources
What's New? The strategy to offer self‐sampling for human papillomavirus testing to increase cervical cancer screening attendance among long‐term non‐attenders has been mostly validated in randomized trials. This real‐life implementation of self‐sampling for long‐term non‐attenders to the routine screening program in the capital region of Sweden ...
K. Miriam Elfström +3 more
wiley +1 more source
TELOMERE ATTACHMENT OF CHROMOSOMES. SOME GENETICAL AND CYTOLOGICAL CONSEQUENCES [PDF]
J A Sved
openalex +1 more source
What's New? Racial disparities in trends of human papillomavirus (HPV)–associated cancers in South Africa have received limited attention. Here, the authors examined cancer incidence rates among South Africans, with stratification by race and sex, for different timeframes across 2011–2022.
Adino T. Tsegaye +7 more
wiley +1 more source

